News & Events

Company Presentation at the 2021 OIS Conference

The IOPerfect breakthrough was presented at the 2021 Ophthalmology Innovation Summit (OIS). Here it is in case you missed. Read more

Leading ophthalmologist joins company as Board member

Prof. David Goldblum, MD, a renowned researcher and industry expert joins the board, bringing much value as the company enters clinical and commercial phases. Read more
David Goldblum

IOPerfect™ clinical study gets thumbs up, recruiting starts next week

A leading hospital in Israel, Assuta Medical Center, will host the pilot study of the IOPerfect™, to include up to 400 eyes, a key company milestone. Read more
Assuta

Glaucoma experts are founding members of Advisory Board

Prof. Robert Weinreb, MD and Prof. Murray Fingeret, O.D, recognized as the world’s top glaucoma experts, join Ophthalmic Sciences and express confidence in technology and its market.